To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...

Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

Ben Simpfendorfer, Partner at Oliver Wyman, explains why having a multi-country manufacturing presence, including China, is ...

Robert F. Kennedy Jr. was forced to walk back his words after he accused a Democratic lawmaker of accepting millions from the ...

Torrent Pharma will emerge among the top 5 domestic pharma players by sales with the acquisition of J B Chemicals and ...

HYDERABAD, India -- The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India’s southern ...

The Middle East life sciences market will grow to $36bn by 2028, driven by R&D investments, digital health adoption, and ...

An explosion and fire at a pharmaceutical factory in Telangana, India, have killed at least 12 people and injured several ...

Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.

Despite the slow trickle of updates on President Donald Trump’s proposed pharmaceutical import tariffs, drugmakers have ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...